Aalto Bio Reagents Ltd.-Biosynth’s Post

We are excited to share that we will be exhibiting at AACC 2023 from 23rd of July - 27th of July 2023. Please visit us at booth 4224 and we are looking forward to seeing everyone attending. We are delighted to offer a range of novel human hybrid IgM monoclonal antibodies for CMV, HSV-1/2, Measles, Mumps, Mycoplasma pneumoniae, Rubella, Toxoplasma gondii and VZV. These are intended to replace hard to find disease state IgM positive human plasma, are produced in mice genetically modified to express human IgM heavy chain constant region. They are then concentrated and spiked into an IgG depleted and delipidised human serum matrix which ensures that the final product is as close as possible to the natural disease state IgM positive human plasma. Testing in both ELISA and bead-based applications shows the products behave in an almost identical manner as the natural source. If you would like to further discuss this product, please visit our website at https://rb.gy/dtsnp or contact us at info@aaltobioreagents.com to meet our commercial team. #aacc2023 #aacc #biorawmaterials #biosupply #plasma #anitbody #monoclonalantibodies

View organization page for Biosynth, graphic

26,219 followers

Join all of our Biosynth divisions this week at AACC booth 4224 Biosynth or booth 3654 Fitzgerald Industries (recently acquired by Biosynth). Come and speak with our expert staff in all three divisions about your upcoming Biologic, Peptide and Chemical projects. We are delighted to offer the world’s first solution to replacing natural human Rubella IgM plasma at AACC 2023 in Anaheim. This Rubella IgM is purified by proprietary methodology from cell culture supernatant, concentrated and supplied as a liquid in IgG depleted and delipidised human serum matrix. All but trace amounts of growth medium animal content have been removed to make this product the most ESG friendly product on the market. The product is confirmed negative for HBsAg, HIV-1, HIV-2 and HCV by FDA approved methods. For more information on this and all of our other new humanized monoclonals go to www.biosynth.com/biologics or come by our booths this week. #Peptides #Chemicals #Biologics #SecuringLifesciencesSupplyChains

To view or add a comment, sign in

Explore topics